Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
IV therapy is not suitable for individuals with certain medical conditions such as kidney disease, heart failure, or known allergies to any of the ingredients
Ipamorelin is a pentapeptide GHRP (Growth Hormone Releasing Peptide) that selectively activates the GHS-R1a receptor to stimulate GH release
The study participants were hypertensive (clinic systolic/diastolic BP of 140-179/90-109 mmHg and 24-hour ambulatory systolic/diastolic BP 130/80 mmHg) patients enrolled in a randomized controlled trial and treated with amlodipine 510 mg or nifedipine gastrointestinal therapeutic system (GITS) 3060 mg once daily
These products are not intended to diagnose, treat, cure, or prevent any disease.
Toxic solvent residues DMF (dimethylformamide) Known liver toxin Associated with reproductive toxicity Must be removed to extremely low limits in GMP drugs DCM (dichloromethane / methylene chloride) Probable human carcinogen Central nervous system depressant Dangerous even in small amounts if injected TFA (trifluoroacetic acid) Corrosive Can remain in peptides as unmeasured TFA salt Pharmaceutical products often convert TFA salts to safer counterions Without validated HPLC, mass spectrometry, and residual solvent testing, patients may be injected with harmful chemical contaminants
US$ 27.22
US$ 22.56
US$ 20.25
